Setting new standards in information exchange for the pharmaceutical and biotech industry
New Guest Co-Chair Joins DPharm: Disruptive Innovations to Advance Clinical Trials
August 10, 2017
We are delighted to welcome Bray Patrick-Lake as our guest co-chair at DPharm: Disruptive Innovations to Advance Clinical Trials. The 7th annual DPharm takes place Sept 7-8 in Boston where Bray, together with Pfizer’s Craig Lipset and Janssen’s Dr Andreas Koester, will host 70 speakers who either demonstrate innovation in clinical trials or get us to think differently about 21st C drug development. Bray is the Director of Stakeholder Engagement at Duke Clinical Research Institute and supports efforts to actively engage patients, health advocacy organizations, and other stakeholders in local and national research programs.
Bray Patrick-Lake has led extensive efforts through the Clinical Trials Transformation Initiative to incorporate patient voice into clinical trial design, conduct, oversight, and regulatory frameworks, as well as improvement of the clinical trial enterprise. She co-chaired the Advisory Committee to the NIH Director’s Working Group responsible for authoring the vision and roadmap to launch the Precision Medicine Initiative Cohort Program. Ms Patrick-Lake served as the Interim Director of Engagement for several months after the program launched and became the All of Research Program, for which she currently serves on the National Advisory Panel. She also leads engagement work at Duke’s Coordinating Center for the NIH Environmental Influences on Child Health Outcomes (ECHO) program and serves on the National Academies of Sciences, Engineering, and Medicine Health Sciences Policy Board.
Ms Patrick-Lake founded a disease advocacy organization for cardiac patients and served as a patient representative at the FDA on a variety of advisory committees and panels, in workgroups for EMA, IMI, NIH, and NAM/IOM, and as a patient stakeholder or co-investigator for AHRQ and PCORI research projects. She is member of the America Cancer Society’s Clinical Trials Steering Committee and has served on the MDEpiNet’s National Medical Device Registry Task Force, the Medical Device Innovation Consortium’s Patient-centered Benefit-Risk Steering Committee, American College of Cardiology (ACC) Foundation’s Patient-centered Care Shared Decision Making and Patient-generated Health Data working groups, and the ACC Transcatheter Valve Therapy Registry Stakeholder Advisory Committee. Ms Patrick-Lake currently also serves as a PCORI reviewer and ambassador.
For information about DPharm, click here.